Skip to content

EPS (Diluted) at other companies

ITG
Integer HoldingsITGR
$0.48+173%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$0.68+38.8%
Haemonetics logo
HaemoneticsHAE
$0.95+28.4%
Abbott logo
AbbottABT
$0.61-19.7%
Baxter International logo
Baxter InternationalBAX
-$0.03-112%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
-$1.11-204%

Other financials

Income statement

See full
Revenue$66.6M+11.2%
Gross profit$48.4M+16.8%
Operating income$17.8M+40.8%
Net income$15.7M+42.4%

Balance sheet

See full
Cash & equivalents$26.9M+6.0%
Total debt$20.9M+20.6%
Total equity$406.6M+17.0%
Total assets$629.5M+13.2%

Cash flow

See full
Operating cash flow$15.1M+67.0%
CapEx$2.8M+101%
Free cash flow$12.3M+60.8%

Valuation

See full
Market cap$2.1B+31.4%
Enterprise value$2.1B+31.6%
P/E33.7×-1.7×
P/S8.2×+1.1×

Profitability

See full
Gross margin72.4%+3.6pp
Operating margin28.5%+5.1pp
Net margin24.3%+4.4pp
FCF margin30.9%+12.7pp

Returns & leverage

See full
Return on equity16.5%+2.8pp
Debt / equity0.1×0.0×
Current ratio14.3×-2.2×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LeMaitre Vascular's EPS (diluted)?
LeMaitre Vascular (LMAT) reported EPS (diluted) of $0.68 in Q1 2026.
How has LeMaitre Vascular's EPS (diluted) changed year-over-year?
LeMaitre Vascular's EPS (diluted) increased by 41.7% year-over-year, from $0.48 to $0.68.
What is the long-term trend for LeMaitre Vascular's EPS (diluted)?
Over 4 years (2021 to 2025), LeMaitre Vascular's EPS (diluted) has grown at a 18.8% compound annual growth rate (CAGR), from $1.26 to $2.51.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.